Principal Financial Group Inc. Sells 14,042 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

Principal Financial Group Inc. decreased its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 6.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 216,933 shares of the company's stock after selling 14,042 shares during the period. Principal Financial Group Inc. owned 0.39% of Astrana Health worth $6,840,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Louisiana State Employees Retirement System purchased a new stake in Astrana Health in the third quarter worth $1,165,000. State of Alaska Department of Revenue purchased a new position in shares of Astrana Health during the 3rd quarter worth approximately $1,373,000. Nisa Investment Advisors LLC purchased a new position in shares of Astrana Health in the 3rd quarter valued at approximately $35,000. New York State Teachers Retirement System bought a new stake in shares of Astrana Health during the third quarter valued at approximately $2,515,000. Finally, QRG Capital Management Inc. purchased a new stake in Astrana Health in the third quarter worth $355,000. Hedge funds and other institutional investors own 52.77% of the company's stock.

Wall Street Analyst Weigh In

ASTH has been the subject of several recent research reports. Truist Financial lowered their price objective on Astrana Health from $59.00 to $50.00 and set a "buy" rating for the company in a research report on Monday, January 13th. Robert W. Baird lowered their price target on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a research report on Monday. Stifel Nicolaus dropped their price objective on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating on the stock in a research note on Thursday, February 20th. Macquarie upgraded Astrana Health to a "hold" rating in a report on Monday, December 16th. Finally, Bank of America decreased their target price on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a report on Tuesday. Two analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $56.83.

Remove Ads

Astrana Health Stock Performance

ASTH stock traded down $0.43 on Thursday, hitting $26.76. The company had a trading volume of 52,242 shares, compared to its average volume of 243,525. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health, Inc. has a 12-month low of $23.12 and a 12-month high of $63.20. The stock has a market cap of $1.51 billion, a price-to-earnings ratio of 20.67, a P/E/G ratio of 1.37 and a beta of 1.20. The stock's 50-day simple moving average is $34.44 and its 200 day simple moving average is $44.05.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of $0.22 by ($0.37). The business had revenue of $665.21 million for the quarter, compared to analysts' expectations of $617.24 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. As a group, equities research analysts expect that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.